Stocks Rebound After Volatile Week as Dow Hits Record High
The Dow Jones industrial average surpassed 50,000 points for the first time, as old line stocks come back into vogue.
Paul Weiss Partners Turned on Brad Karp After Learning Extent of His Epstein Ties
Mr. Karp resigned as chairman of the elite law firm after senior partners met to decide his future.
Fear of AI Replacing Software Makers Hits Stocks. Here’s What to Know.
The prospect of disruptions from artificial intelligence has hung over the economy for years. But this week advances in software tools precipitated a sell-off on Wall Street.
Google Workers Demand End to Cloud Services for Immigration Agencies
More than 800 employees delivered a petition to management, condemning the Trump administration’s use of Google technology in immigration enforcement.
TrumpRx: What to Know About Insurance Benefits, Pricing and Savings
People may be able to pay less for prescriptions with their insurance rather than via the new government website. The Trump drugstore is meant to help people buy medications using their own money.
Stellantis’s Shift Away From Electric Cars Will Cost It $26 Billion
The company, which owns Chrysler, Fiat, Jeep and Peugeot, is changing its strategy to gasoline and hybrid vehicles in an effort to revive weak sales.
A Reprieve for Veterans Applying for V.A. Mortgages
House Republicans have scaled back a proposal to charge higher fees for the loans after opposition from veterans groups. But it still includes a higher fee for refinancings.
7 Brothers, a Rom-com and a Dream
These siblings (and an in-law) turned their childhood love of Hollywood into a family enterprise that has resulted in “Solo Mio,” starring Kevin James.
A Reprieve for the Markets, but For How Long?
Technology stocks and Bitcoin are showing signs of a rebound after a disastrous week. But investors remain on edge about whether more pain is in store.
Europe Accuses TikTok of ‘Addictive Design’ and Pushes for Change
European Union regulators said the app’s infinite scroll and personalized algorithm led to “compulsive” behavior, especially among children.
Toyota Names Kenta Kon C.E.O. as Automaker Faces Tariffs and Increasing Competition
The world’s biggest automaker has navigated the industry’s turbulent E.V. transition, but is looking to new leadership to manage intensifying geopolitical challenges.
The Dark Side of A.I. Weighs on the Stock Market
The prospect of disruptions from artificial intelligence has hung over the economy for years. But this week advances in software tools precipitated a sell-off on Wall Street.
Nike and Trump’s Supporters Have Been on a Collision Course for Years
The chair of the Equal Employment Opportunity Commission has long opposed diversity initiatives like those that Nike embraced.
‘Gang Stuff’ and ‘Illicit Trysts’: How Epstein Sought Leverage With the Wealthy
Jeffrey Epstein drafted letters to men like the retail billionaire Leslie Wexner in which he hinted at shared secrets.
It’s Time to Rethink the Standard Investment Advice. But Not Too Much.
With signs of trouble popping up in financial markets, investors need to decide whether they can ignore the turmoil, our columnist says.
The 2026 Super Bowl Ads (So Far), Ranked
Here is our critic’s survey of this year’s Super Bowl commercials, from best to worst to A.I.
2025 Tax Returns: Here’s What to Know About Filing This Year
Many Americans will see bigger refunds and new deductions, while others may be revisiting the dreaded alternative minimum tax. Don’t panic just yet.
An Indian Film Embraces a Taj Majal Conspiracy Theory
The internet and a new film have breathed life into old conspiracy theories about one of the world’s most famous landmarks.
Uber Found Liable in Rape by Driver, Setting Stage for Thousands of Cases
In a federal bellwether case, the jury ordered the ride-hailing giant to pay $8.5 million to Jaylynn Dean, who said one of its drivers assaulted her in 2023.
TrumpRx, the President’s Online Drugstore, Opens for Business
TrumpRx is aimed at helping patients use their own money to buy medicines. But researchers who study drug pricing warned that many patients could pay too much if they use the site.